Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C6H8N2O8 |
Molecular Weight | 236.1363 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O
InChI
InChIKey=MOYKHGMNXAOIAT-JGWLITMVSA-N
InChI=1S/C6H8N2O8/c9-7(10)15-3-1-13-6-4(16-8(11)12)2-14-5(3)6/h3-6H,1-2H2/t3-,4+,5-,6-/m1/s1
Molecular Formula | C6H8N2O8 |
Molecular Weight | 236.1363 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:16:13 UTC 2023
by
admin
on
Sat Dec 16 16:16:13 UTC 2023
|
Record UNII |
IA7306519N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
WHO-VATC |
QC05AE02
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
NDF-RT |
N0000007647
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
NDF-RT |
N0000007647
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
NDF-RT |
N0000009909
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
NDF-RT |
N0000007647
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
WHO-VATC |
QC01DA08
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
WHO-ATC |
C01DA08
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
LIVERTOX |
522
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
WHO-ATC |
C05AE02
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
NDF-RT |
N0000007647
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
WHO-ATC |
C01DA58
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
WHO-VATC |
QC01DA58
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
CFR |
21 CFR 250.102
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
12.1
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
||
|
NDF-RT |
N0000175415
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
80038
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
IA7306519N
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
CHEMBL6622
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
6883
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
C29134
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
IA7306519N
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
6061
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
1505
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
100000091562
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
996
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
6058
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB08335MIG
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
m6541
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | Merck Index | ||
|
ISOSORBIDE DINITRATE
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
7051
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
87-33-2
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
3417
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
D007548
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
DB00883
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
DTXSID0045832
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY | |||
|
201-740-9
Created by
admin on Sat Dec 16 16:16:14 UTC 2023 , Edited by admin on Sat Dec 16 16:16:14 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
It usually contains approximately 25 percent of isosorbide dinitrate
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MINOR
PLASMA
|
||
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
calculated as potassium nitrate
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||